2016
DOI: 10.1186/s13046-016-0289-z
|View full text |Cite
|
Sign up to set email alerts
|

Direct targeting sperm-associated antigen 9 by miR-141 influences hepatocellular carcinoma cell growth and metastasis via JNK pathway

Abstract: BackgroundThe aberrant expression of sperm-associated antigen 9 (SPAG9) is associated with numerous cancers, including hepatocellular carcinoma (HCC). The exploration of molecules and mechanisms regulating SPAG9 expression may provide new options for HCC therapy.MethodsMiRNA target prediction programs were used to explore SPAG9-targeted miRNAs. SPAG9 and miR-141 expression were detected in HCC tissues and cell lines by Western blot and real-time PCR. Dual-luciferase reporter assay was utilized to validate SPAG… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
30
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 41 publications
(32 citation statements)
references
References 40 publications
(40 reference statements)
0
30
0
Order By: Relevance
“…These data indicate a tumor suppressive role for miR-141 in HCC patients and so its decreased expression levels indicate progressive or increased severity of HCC. In support of this assumption, Lou et al [34] found MiR-141 over expression resulted in significantly reduced cell proliferation, invasion, and migration effects on HCC cells.…”
Section: Discussionmentioning
confidence: 84%
“…These data indicate a tumor suppressive role for miR-141 in HCC patients and so its decreased expression levels indicate progressive or increased severity of HCC. In support of this assumption, Lou et al [34] found MiR-141 over expression resulted in significantly reduced cell proliferation, invasion, and migration effects on HCC cells.…”
Section: Discussionmentioning
confidence: 84%
“…Other studies have shown that the c-Jun N-terminal kinase (JNK) signaling pathway is involved in cell proliferation and differentiation. Its dysfunction can cause ischemia/reperfusion injury [6], diabetes [7], or tumors [8]. Thus, the JNK signaling pathway has become a potential clinical molecular therapeutic target.…”
Section: Introductionmentioning
confidence: 99%
“…Several differentially expressed miRNAs have been found to be immune-related in mammals, such as miR-148/152, miR-101a, miR-141/200c, miR-146b, miR-217 and miR-375 [50,51,52,53,54,55,56]. A previous study demonstrated that the miR-148 and miR-152, two members of miR-148 family, were significantly increased in dendritic cells by TLR agonists, which inhibited the up-regulation of MHC II expression and the production of cytokine via targeting CaMKIIα, and might contribute to immune homeostasis [50].…”
Section: Discussionmentioning
confidence: 99%
“…miR-141 and miR-200c, belonging to the highly conserved miR-200 family, whose members are considered as tumor suppressors [52], can promote the mesenchymal-epithelial transition, and inhibit cell invasion by suppressing the Zeb2 and Snail1 transcriptional repressor complexes [53]. In addition, miR-200b/c and miR-217 regulate the expression of mortalin and the quantity of MACs (complement membrane attack complex) deposited on the target cells during complement activation to resist complement membrane attack [55], and the decreased miR-375 can activate JAK2-STAT3 pathway and promote the proliferation and migration of gastric epithelial cells in response to Helicobacter pylori infection [56].…”
Section: Discussionmentioning
confidence: 99%